Free Trial

Regulus Therapeutics (RGLS) SEC Filings & 10K Form

Regulus Therapeutics logo
$7.92 +0.02 (+0.19%)
As of 10:11 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Regulus Therapeutics SEC Filings

DateFilerForm TypeView
05/15/2025
7:35 AM
Regulus Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SCHEDULE 13G/A
05/08/2025
7:23 PM
Regulus Therapeutics (Subject)
Form SC14D9C
05/01/2025
4:00 PM
NOVARTIS AG (Filed by)
Regulus Therapeutics (Subject)
Form SC TO-C
04/30/2025
5:16 PM
Nunn Jason Raleigh (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
4:00 PM
NOVARTIS AG (Filed by)
Regulus Therapeutics (Subject)
Form SC TO-C
04/30/2025
7:27 AM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
7:30 AM
Regulus Therapeutics (Subject)
Form SC14D9C
03/27/2025
6:15 AM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2025
4:00 PM
CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
4:00 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
4:00 PM
BALTIMORE DAVID (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
4:00 PM
Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
4:00 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
3:14 PM
Regulus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/15/2025
4:00 PM
Klassen Preston (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
4:00 PM
CALSADA CRISPINA (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
4:00 PM
Hagan Joseph P (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2025
4:00 PM
Aker Christopher Ray (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:32 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
11/14/2024
1:35 PM
DAFNA Capital Management LLC (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G/A
11/07/2024
3:26 PM
Regulus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
3:02 PM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Regulus Therapeutics (Subject)
Form SC 13G
08/08/2024
3:24 PM
Regulus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2024
3:18 PM
Collier Kathryn J (Reporting)
Regulus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
6:23 AM
Regulus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RGLS) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners